ea0081oc8.2 | Oral Communications 8: Calcium and Bone | ECE2022
Al-Mashhadi Zheer Kejlberg
, Viggers Rikke
, Starup-Linde Jakob
, Vestergaard Peter
, Gregersen Soren
Background: Type 2 diabetes mellitus (T2D) is associated with an increased risk of fractures. Research on the effects of sodium-glucose cotransporter 2 (SGLT-2) inhibitors is scarce and unsettled. We aimed to investigate the risk of major osteoporotic fractures (MOF) i.e., hip, vertebral, humerus, and forearm fractures with SGLT2 inhibitors compared to glucagon-like peptide 1 (GLP-1) receptor agonists when either is used in combination with metformin.<p class...